These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8481757)

  • 1. Clozapine, cognition, and schizophrenia.
    Launer M
    Br J Psychiatry; 1993 Apr; 162():567-8. PubMed ID: 8481757
    [No Abstract]   [Full Text] [Related]  

  • 2. Cognitive impairment and clozapine.
    Carter J; Thrasher S; Thornicroft G
    Br J Psychiatry; 1994 Jan; 164(1):132-3. PubMed ID: 8137103
    [No Abstract]   [Full Text] [Related]  

  • 3. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.
    Hagger C; Buckley P; Kenny JT; Friedman L; Ubogy D; Meltzer HY
    Biol Psychiatry; 1993 Nov; 34(10):702-12. PubMed ID: 8292674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of clozapine on cognitive function in schizophrenia.
    Lee MA; Thompson PA; Meltzer HY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():82-7. PubMed ID: 7961582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of clozapine on neurocognition: an overview.
    Goldberg TE; Weinberger DR
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():88-90. PubMed ID: 7525543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clozapine on perceptual abnormalities and sensory gating: a preliminary cross-sectional study in schizophrenia.
    Micoulaud-Franchi JA; Aramaki M; Geoffroy PA; Richieri R; Cermolacce M; Faget C; Ystad S; Kronland-Martinet R; Lancon C; Vion-Dury J
    J Clin Psychopharmacol; 2015 Apr; 35(2):184-7. PubMed ID: 25587694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of clozapine on cognitive functioning in schizophrenia.
    McGurk SR
    J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine conflict.
    Carpenter WT; Conley RR; Buchanan RW; Breier A; Tamminga CA
    Am J Psychiatry; 1996 Nov; 153(11):1505-7. PubMed ID: 8890695
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurocognitive functioning and facial affect recognition in treatment-resistant schizophrenia treated with clozapine.
    Machado de Sousa JP; Hallak JE
    Schizophr Res; 2008 Dec; 106(2-3):371-2. PubMed ID: 18845421
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluating the effects of antipsychotics on cognition in schizophrenia. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():35-40. PubMed ID: 9766618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of clozapine in the treatment of schizophrenia.
    Meltzer HY; Alphs LD; Bastani B; Ramirez LF; Kwon K
    Pharmacopsychiatry; 1991 Mar; 24(2):44-5. PubMed ID: 1852789
    [No Abstract]   [Full Text] [Related]  

  • 12. Clozapine: is another view valid?
    Meltzer HY
    Am J Psychiatry; 1995 Jun; 152(6):821-5. PubMed ID: 7755109
    [No Abstract]   [Full Text] [Related]  

  • 13. Placebo-controlled trial of glycine added to clozapine in schizophrenia.
    Evins AE; Fitzgerald SM; Wine L; Rosselli R; Goff DC
    Am J Psychiatry; 2000 May; 157(5):826-8. PubMed ID: 10784481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.
    Krakowski MI; Czobor P; Nolan KA
    J Clin Psychopharmacol; 2008 Oct; 28(5):485-93. PubMed ID: 18794642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine decreases smoking in patients with chronic schizophrenia.
    McEvoy J; Freudenreich O; McGee M; VanderZwaag C; Levin E; Rose J
    Biol Psychiatry; 1995 Apr; 37(8):550-2. PubMed ID: 7619979
    [No Abstract]   [Full Text] [Related]  

  • 16. A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.
    Goff DC; Lamberti JS; Leon AC; Green MF; Miller AL; Patel J; Manschreck T; Freudenreich O; Johnson SA
    Neuropsychopharmacology; 2008 Feb; 33(3):465-72. PubMed ID: 17487227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis.
    Tiihonen J; Wahlbeck K; Kiviniemi V
    Schizophr Res; 2009 Apr; 109(1-3):10-4. PubMed ID: 19186030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from MATRICS.
    Marder SR
    Schizophr Bull; 2011 Mar; 37(2):233-4. PubMed ID: 21325472
    [No Abstract]   [Full Text] [Related]  

  • 19. One-year follow-up of 24 patients in a clinical trial of clozapine.
    Davies MA; Conley RR; Schulz SC; Bell-Delaney J
    Hosp Community Psychiatry; 1991 Jun; 42(6):628-9. PubMed ID: 1864575
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of clozapine in treatment-refractory schizophrenia.
    Kuoppasalmi K; Rimon R; Naukkarinen H; Lang S; Sandqvist A; Leinonen E
    Schizophr Res; 1993 Jun; 10(1):29-32. PubMed ID: 8369229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.